A comparative study of carbonic anhydrase activity in lymphocytes from colorectal cancer tissues and adjacent healthy counterparts

References

• Bray F, Ferlay J, Soerjomataram I, et al. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2020;70:1651.
   Web of Science ®Google Scholar
• Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 2020;5:22.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol 2018;29:44–70.
   PubMed Web of Science ®Google Scholar
• Johdi NA, Sukor NF. Colorectal cancer immunotherapy: options and strategies. Front Immunol 2020;11;1624.
   PubMed Web of Science ®Google Scholar
• Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. New Engl J Med 2015;372:2509–20.
   PubMed Web of Science ®Google Scholar
• Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 2017;18:1182–91.
   PubMed Web of Science ®Google Scholar
• Sahin IH, Akce M, Alese O, et al. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms. Br J Cancer 2019;121:809–18.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010;20:51–6.
   PubMed Web of Science ®Google Scholar
• Chiche J, Ilc K, Laferriere J, et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009;69:358–68.
   PubMed Web of Science ®Google Scholar
• Annunziato G, Angeli A, D'Alba F, et al. Discovery of new potential anti-infective compounds based on carbonic anhydrase inhibitors by rational target-focused repurposing approaches. ChemMedChem 2016;11:1904–14.
   PubMed Web of Science ®Google Scholar
• Ozensoy Guler O, Capasso C, Supuran CT. A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzyme Inhib Med Chem 2016;31:689–94.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem 2016;24:1115–20.
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, De Simone G, et al. Cloning, expression and purification of the complete domain of the eta-carbonic anhydrase from Plasmodium falciparum. J Enzyme Inhib Med Chem 2016;31:54–9.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the carbonic anhydrases from two pathogens of the oral cavity: streptococcus mutans and Porphyromonas gingivalis. Curr Top Med Chem 2016;16:2359–68.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7:56.
   PubMed Web of Science ®Google Scholar
• Aspatwar A, Tolvanen MEE, Barker H, et al. Carbonic anhydrases in metazoan model organisms: molecules, mechanisms, and physiology. Physiol Rev 2022;102:1327–83.
   PubMed Web of Science ®Google Scholar
• Viikila P, Kivela AJ, Mustonen H, et al. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. World J Gastroenterol 2016;22:8168–77.
   PubMed Web of Science ®Google Scholar
• Barathova M, Grossmannova K, Belvoncikova P, et al. Impairment of hypoxia-induced CA IX by beta-blocker propranolol-impact on progression and metastatic potential of colorectal cancer cells. Int J Mol Sci 2020;21:8760.
   PubMed Web of Science ®Google Scholar
• Liao SY, Brewer C, Zavada J, et al. Identification of the Mn antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598–609.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Parkkila AK, et al. Carbonic anhydrase IX, MN/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997;112:398–408.
   PubMed Web of Science ®Google Scholar
• Zhang BY, Thompson RH, Lohse CM, et al. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. BJU Int 2013;111:1046–53.
   PubMed Web of Science ®Google Scholar
• Hains DS, Chen X, Saxena V, et al. Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility. Am J Physiol Renal Physiol 2014;307:F869–80.
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 2018;32:1267–84.
   PubMed Web of Science ®Google Scholar
• Niccolai E, Russo E, Baldi S, et al. Significant and conflicting correlation of IL-9 With prevotella and bacteroides in human colorectal cancer. Front Immunol 2021;11:573158.
   PubMed Web of Science ®Google Scholar
• Niccolai E, Ricci F, Russo E, et al. The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer. Front Immunol 2017;8:1900.
   PubMed Web of Science ®Google Scholar
• Lavin Y, Kobayashi S, Leader A, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 2017;169:750–65 e17.
   PubMed Web of Science ®Google Scholar
• Sadanandam A, Lyssiotis CA, Homicsko K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med 2013;19:619–25.
   PubMed Web of Science ®Google Scholar
• Havel JJ, Chowell D, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 2019;19:133–50.
   PubMed Web of Science ®Google Scholar
• De Luca V, Del Prete S, Supuran CT, Capasso C. Protonography, a new technique for the analysis of carbonic anhydrase activity. J Enzyme Inhib Med Chem 2015;30:277–82.
   PubMed Web of Science ®Google Scholar
• Zhou DW, Noviello C, D'Ambrosio C, et al. Growth factor receptor-bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain. J Biol Chem 2004;279:25374–80.
   PubMed Web of Science ®Google Scholar
• Antoniali G, Serra F, Lirussi L, et al. Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. Nat Commun 2017;8:797–814.
   PubMed Web of Science ®Google Scholar
• Joshi RN, Stadler C, Lehmann R, et al. TcellSubC: an atlas of the subcellular proteome of human T cells. Front Immunol 2019;10:2708–18.
   PubMed Web of Science ®Google Scholar
• Riaz T, Sollid LM, Olsen I, de Souza GA. Quantitative proteomics of gut-derived Th1 and Th1/Th17 clones reveal the presence of CD28 + NKG2D-Th1 cytotoxic CD4+ T cells. Mol Cell Proteomics 2016;15:1007–16.
   PubMed Web of Science ®Google Scholar
• Voigt J, Malone DFG, Dias J, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol 2018;48:1456–69.
   PubMed Web of Science ®Google Scholar
• Zhao M, Jia SJ, Gao XF, et al. Comparative analysis of global proteome and lysine acetylome between naive CD4+ T Cells and CD4+ T follicular helper cells. Front Immunol 2021;12:643441–58.
   PubMed Web of Science ®Google Scholar
• Supuran CT. The tumor-associated metalloenzyme carbonic anhydrase IX (CA IX) as a drug target. Metal Ions Biol Med 2008;10:379–81.
   Google Scholar
• Zhou R, Huang WJ, Yao YQ, et al. CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells. Int J Oncol 2013;43:611–21.
   PubMed Web of Science ®Google Scholar
• Pan PW, Leppilampi M, Pastorekova S, et al. Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CA IX-deficient (Car9-/-) mice. J Physiol-London 2006;571:319–27.
   PubMed Web of Science ®Google Scholar
• Amedei A, Niccolai E, Della Bella C, et al. Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. Cancer Immunol Immun 2009;58:1821–32.
   Web of Science ®Google Scholar
• Amedei A, Niccolai E, Benagiano M, et al. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. Cancer Immunol Immunother 2013;62:1249–60.
   PubMed Web of Science ®Google Scholar
• White MA. Change in pH of expressed prostatic secretion during course of prostatitis. Proc R Soc Med 1975;68:511–13.
   PubMedGoogle Scholar
• Tang XX, Fok KL, Chen H, et al. Lymphocyte CFTR promotes epithelial bicarbonate secretion for bacterial killing. J Cell Physiol 2012;227:3887–94.
   PubMed Web of Science ®Google Scholar